comparemela.com

Latest Breaking News On - Aarti speciality chemicals limited - Page 1 : comparemela.com

Moderate gains seen at open, but crude, FPI flow to anchor direction

Moderate gains seen at open, but crude, FPI flow to anchor direction March 08, 2021 × Asian markets in early trade on Monday are up 0.5-1.5%; US markets on Friday closed up 1.55-2%; analysts fear the market may see volatility The Indian stock markets, after falling a couple of days, are expected to open on a positive note on Monday, thanks to global markets. The SGX Nifty, ruling at 15,080, points to a 130-point gain for Nifty futures, which on Friday closed at 14,953 on the NSE. Asian markets in early trade on Monday are up in the range of between 0.5 and 1.5 per cent. Australian indices are ruling with the biggest gains on Monday, while China, Japan and Taiwan too are firm. The US markets on Friday too closed up 1.55-2 per cent.

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector Posted On: 2021-03-06 04:25:29 (Time Zone: Arizona, USA) Aarti Speciality Chemicals Limited (ASCL), a wholly-owned subsidiary of Aarti Drugs Limited (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India s recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector. Government of India s Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-reliance and reducing im

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.